By
Publication Date: 2026-02-23 17:56:00
- In the lead-up to Nutanix’s upcoming quarterly report, Wall Street analysts have projected earnings of $0.45 per share, implying a year-on-year decline and reflecting a slight downward revision in estimates over the past month.
- At the same time, expectations for higher product and other key revenue segments highlight a complex picture in which profitability pressures coexist with anticipated top-line growth.
- Next, we’ll examine how softer earnings expectations alongside anticipated product revenue strength could influence Nutanix’s broader investment narrative.
AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
Nutanix Investment Narrative Recap
To own Nutanix, you really have to believe in its role as a core platform for hybrid and multi cloud infrastructure, even as competition and IT spending cycles remain key uncertainties. The latest pullback in near term earnings expectations does not materially change the biggest short term catalyst, which is the upcoming Q2 FY2026 report, nor the key risk around margin pressure if operating expenses stay elevated relative to revenue growth.
Among recent updates, Nutanix’s Q1 FY2026 results and Q2/FY2026 revenue guidance are most relevant here, because they set the reference point against which this softer $0.45 EPS estimate will be judged. With Q2 revenue guided to…
